| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.86▲ | 8.90▼ | 8.92▼ | 8.70▲ | 7.43▲ |
| MA10 | 8.84▲ | 8.95▼ | 8.89▼ | 7.84▲ | 7.03▲ |
| MA20 | 8.87▼ | 8.86▲ | 8.86▲ | 7.28▲ | 6.31▲ |
| MA50 | 8.93▼ | 8.89▼ | 8.56▲ | 6.95▲ | 7.67▲ |
| MA100 | 8.90▼ | 8.39▲ | 7.33▲ | 6.17▲ | 5.97▲ |
| MA200 | 8.85▲ | 7.32▲ | 7.26▲ | 7.52▲ | 14.88▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | -0.010▼ | -0.032▼ | 0.252▲ | 0.333▲ |
| RSI | 48.065▼ | 49.916▼ | 55.267▲ | 66.564▲ | 59.724▲ |
| STOCH | 61.466 | 37.729 | 69.390 | 83.505▲ | 64.337 |
| WILL %R | -41.379 | -54.430 | -38.053 | -12.022▲ | -11.069▲ |
| CCI | 6.140 | -91.643 | 25.792 | 84.114 | 226.618▲ |
|
Friday, August 15, 2025 04:49 AM
The market for Emergent BioSolutions Inc.'s ( NYSE:EBS ) stock was strong after it released a healthy earnings ...
|
|
Thursday, August 14, 2025 08:04 AM
What Happened: DeGolyer's decision to sell 7,844 shares of Emergent BioSolutions was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value of the ...
|
|
Tuesday, August 12, 2025 09:46 AM
Emergent BioSolutions' strong Q2 2025 results and strategic turnaround signal robust growth potential and stock gains ahead. Click here to read why EBS is a Buy.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 8.87 | 9.085 | 8.78 | 8.84 | 1,093,446 |
| 14/08/25 | 8.62 | 8.82 | 8.52 | 8.82 | 648,630 |
| 13/08/25 | 9.00 | 9.20 | 8.73 | 8.79 | 1,458,460 |
| 12/08/25 | 8.24 | 9.13 | 8.24 | 8.91 | 1,944,881 |
| 11/08/25 | 8.60 | 8.95 | 8.0617 | 8.16 | 1,327,048 |
| 08/08/25 | 8.25 | 9.28 | 8.16 | 8.57 | 2,711,000 |
| 07/08/25 | 6.54 | 8.25 | 6.515 | 8.24 | 5,782,876 |
| 06/08/25 | 6.10 | 6.20 | 6.03 | 6.03 | 911,800 |
| 05/08/25 | 5.98 | 6.135 | 5.87 | 6.10 | 898,308 |
| 04/08/25 | 5.70 | 6.04 | 5.62 | 5.95 | 745,600 |
|
|
||||
|
|
||||
|
|